Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

Show other versions (1)

BACKGROUND: National and international guidelines call for the treatment of primary HIV infection (PHI) with combination antiretroviral therapy, although the ideal timing and duration of this intervention is unknown. Recent immunological studies of antiretroviral therapy on small numbers of patient...

Full description

Bibliographic Details
Main Authors:	Fidler, S, Oxenius, A, Brady, M, Clarke, J, Cropley, I, Babiker, A, Zhang, H, Price, D, Phillips, R, Weber, J
Format:	Journal article
Language:	English
Published:	2002

Similar Items

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2002)

Short-course antiretroviral therapy in primary HIV infection.
by: Fidler, S, et al.
Published: (2013)

Virological remission after antiretroviral therapy interruption in female African HIV seroconverters
by: Gossez, M, et al.
Published: (2018)

Immunologic and Virologic Outcomes of Obese and Nonobese Incarcerated Adults on Antiretroviral Therapy for HIV Infection
by: Kristen L. Bunnell PharmD, et al.
Published: (2018-01-01)

Immunological and virological benefits resulted from short-course treatment during primary HIV infection: a meta-analysis.
by: Jingjing Chen, et al.
Published: (2013-01-01)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
by: Mulugeta Melku, et al.
Published: (2020-08-01)

Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infection.
by: Phillips, A, et al.
Published: (2004)

Highly active antiretroviral therapy interruption: predictors and virological and immunologic consequences.
by: Touloumi, G, et al.
Published: (2006)

Variable fate of virus-specific CD4(+) T cells during primary HIV-1 infection.
by: Oxenius, A, et al.
Published: (2001)

Effects of adherence to antiretroviral therapy on body mass index, immunological and virological status of Nigerians living with HIV/AIDS
by: S.A. Olowookere, et al.
Published: (2016-03-01)

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment
by: E. I. Veselova, et al.
Published: (2020-06-01)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
by: Mamo A, et al.
Published: (2022-02-01)

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.
by: Ricardo Sobhie Diaz, et al.
Published: (2015-01-01)

Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia [Corrigendum]
by: Mamo A, et al.
Published: (2022-03-01)

Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
by: Phasomsap Chayapa, et al.
Published: (2011-10-01)

Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia
by: Genet Gebrehiwet Hailu, et al.
Published: (2021-06-01)

Gender differences in clinical, immunological, and virological outcomes in highly active antiretroviral-treated HIV&ndash;HCV coinfected patients
by: Joel Emery, et al.
Published: (2010-05-01)

HIV-1 DNA predicts disease progression and post-treatment virological control.
by: Williams, J, et al.
Published: (2014)

Association of age with mortality and virological and immunological response to antiretroviral therapy in rural South African adults.
by: Portia C Mutevedzi, et al.
Published: (2011-01-01)

HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy.
by: Janneke H van Dijk, et al.
Published: (2011-04-01)

Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection.
by: Fox, J, et al.
Published: (2008)

Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults
by: Eugène Messou, et al.
Published: (2008-06-01)

Expression of type I interferon-associated genes at antiretroviral therapy interruption predicts HIV virological rebound
by: P. Zacharopoulou, et al.
Published: (2022-01-01)

Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.
by: Vlada V Melekhin, et al.
Published: (2009-09-01)

Factors predicting discordant virological and immunological responses to antiretroviral therapy in HIV-1 clade C infected Zulu/Xhosa in South Africa.
by: Boris Julg, et al.
Published: (2012-01-01)

Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy
by: Stöhr, W, et al.
Published: (2013)

Virologic and immunologic status of children with HIV-TB co-infections
by: Djatnika Setiabudi, et al.
Published: (2021-03-01)

The immunological and virological consequences of planned treatment interruptions in children with HIV infection
by: Klein, N, et al.
Published: (2013)

The relationship of hair glucocorticoid levels to immunological and virological outcomes in a large cohort of combination antiretroviral therapy treated people living with HIV
by: Quan Zhang, et al.
Published: (2022-03-01)

Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection
by: Jintanat Ananworanich, et al.
Published: (2016-01-01)

Sustained virological response on second-line antiretroviral therapy following virological failure in HIV-infected patients in rural South Africa.
by: Annelot F Schoffelen, et al.
Published: (2013-01-01)

The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
by: Nigel Klein, et al.
Published: (2013-01-01)

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.
by: David A Wohl, et al.
Published: (2013-01-01)

Adherence to contemporary antiretroviral treatment regimens and impact on immunological and virologic outcomes in a US healthcare system.
by: Christophe T Tchakoute, et al.
Published: (2022-01-01)

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)
by: Oyomopito, R., et al.
Published: (2010)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse.
by: Vasiliver-Shamis, G, et al.
Published: (2010)

HIV-1 Virological Synapse is not Simply a Copycat of the Immunological Synapse
by: Gaia Vasiliver-Shamis, et al.
Published: (2010-05-01)

Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
by: Julie Kadima, et al.
Published: (2018-01-01)

Virological blips and predictors of post treatment viral control after stopping ART started in primary HIV infection
by: Fidler, S, et al.
Published: (2017)

Characterization of virologic failure after an initially successful 48-week course of antiretroviral therapy in HIV/AIDS outpatients treated in Santos, Brazil
by: Marcos M. Caseiro, et al.